Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 7, 2024, before the open
10-Q filed May 7, 2024, 37 days after period end · 0001171843-24-002618
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $24.51M | $29.98M | $28.78M | $26.99M |
| Net Income | -$4.69M | $622.00K | -$6.88M | -$669.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.11 |
| $0.01 |
| -$0.17 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
